Rythmodan Retard 250 mg Prolonged-release Tablets Írland - enska - HPRA (Health Products Regulatory Authority)

rythmodan retard 250 mg prolonged-release tablets

sanofi-aventis ireland limited t/a sanofi - disopyramide - prolonged-release tablet - 250 milligram(s) - antiarrhythmics, class ia; disopyramide

Rythmodan Retard 250mg tablets Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

rythmodan retard 250mg tablets

dowelhurst ltd - disopyramide phosphate - modified-release tablet - 250mg

Rythmodan Retard 250mg tablets Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

rythmodan retard 250mg tablets

waymade healthcare plc - disopyramide phosphate - modified-release tablet - 250mg

Rythmodan Retard 250mg tablets Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

rythmodan retard 250mg tablets

sigma pharmaceuticals plc - disopyramide phosphate - modified-release tablet - 250mg

RYTHMODAN CAPSULE Kanada - enska - Health Canada

rythmodan capsule

cheplapharm arzneimittel gmbh - disopyramide - capsule - 100mg - disopyramide 100mg - class ia antiarrythmics